Progyny sets $200 million credit facility, expects Q2 results slightly above guidance
Progyny entered a $200.0 million revolving credit facility dated July 1, 2025, maturing July 1, 2030. The revolver was undrawn at closing, and the company said it has no planned use for it now. In a July 8 press release, the company also said Q2 2025 revenue, Adjusted net income and Adjusted EBITDA are expected to be slightly above the ranges it gave in May.
- $200.0 million revolving loan commitments, undrawn at closing, maturing July 1, 2030
- Borrowings are secured by substantially all assets and guaranteed by domestic subsidiaries; covenants include a maximum Total Leverage Ratio of 3.50 to 1.00 and a minimum Interest Coverage Ratio of 3.00 to 1.00
- Q2 2025 revenue, Adjusted net income and Adjusted EBITDA expected slightly above the ranges provided in May
- Q2 2025 results to be reported after market close on August 7, 2025